Angiotensin-converting-enzyme inhibitors in early pregnancy

Lancet

Volumn 350, Issue 9089, 1997, Pages 1446-1447

  Lip, Gregory Y H ^a   Churchill, David ^b   Beevers, Michèle ^b   Auckett, Ann ^b   Beevers, D Gareth ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BISOPROLOL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BONE MALFORMATION; CLINICAL ARTICLE; FEMALE; FETUS MORTALITY; HUMAN; HYPERTENSION; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LUNG HYPOPLASIA; MUSCLE CONTRACTURE; NEWBORN DEATH; OLIGOHYDRAMNIOS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0031583719     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64207-9     Document Type: Article

References (5)

1. Shotan A, Widerhorn J, Hurst E, Elkayam U. Risk of angiotensin converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms and recommendations for use. Am J Med 1994; 96: 451-56.
2. Pryde PG, Stedman AB, Nugent CE, Barr M. Angiotensin converting enzyme inhibitor foetopathy. J Am Soc Nephrol 1993; 3: 1575-82.
3. Hanssens SM, Kierse MJNC, Vankelecom F, Vanassche FA. Foetal and neonatal effects of treatment with angiotensin converting enzyme inhibitors in pregnancy. Obstet Gynaecol 1991; 78: 128-35.
4. Nightingale FL. Warnings on the use of ACE inhibitors in the second and third trimester of pregnancy. JAMA 1992; 267: 244-45.
5. Editorial. Are ACE inhibitors safe in pregnancy? Lancet 1989; ii: 482-83.